JPRN-UMIN000026460已完成未知
A Study for the investigation of symptomatic improvement and safety of INJUV ingestion in individuals with knee and low back pain - A Study for the investigation of symptomatic improvement and safety of INJUV ingestion in individuals with knee and low back pain
Anti-Aging Bank Co.,Ltd.0 个研究点目标入组 12 人开始时间: 2017年3月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 55years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •[1]Individuals receiving medical drugs for treatment of chronic diseases [2]Individuals receiving outpatient care (except for bonesetters, chiropractors, massagers) for knee and/or low back pain [3]Individuals with history of palliative therapy (hyaluronic acid, steroid injection, etc.) or surgical therapy (arthroscopic osteotomy, artificial joint, bolt fixation surgery, etc.)on knees and/or waist [4]Individuals under treatment or with history of mental disorders, sleep disorders, hypertension, diabetes, lipid metabolism abnormality, or other serious disorders [5]Individuals receiving/received medical drug treatment for the past 1 month except for temporary relief medication for headache, menstrual pain, common cold, etc. [6]Individuals with history of serious diseases (hepatic, renal, cardiovascular, respiratory, hematologic, etc.) [7]Individuals with history of gastrointestinal disorders except for appendicitis [8]Individuals with inflammatory disorders such as chronic sinusitis, periodontal disease, bronchitis, etc. [9]Individuals with >=30.0kg/m2 BMI [10]Individuals donated blood >200ml in past 1 month or >400ml in past 3 months [11]Individuals with serious anemia [12]Individuals deemed sensitive to the test product or highly allergic to foods or medical drugs [13]Individuals continually consumed health foods that may interfere the study results (especially glucosamine, chondroitin, etc.) in the past 3 months except for general nutritional supplements [14]Individuals with alcohol intake exceeding 40mg/day,200mg/week as ethanol volume [15]Smokers or ex-smokers within one year after quitting [16]Individuals who may significantly change exercise habit or lifestyle during the study period [17]Individuals participating or planning to join the other clinical investigations during the study period [18]Pregnant or lactating women (expected, desired inclusive) [19]Individual with potential conflict of interests etc.
研究者
相似试验
尚未招募
不适用
Investigation of symptomatology and underpinning neural network, and biomarkers of patients with focal and diffuse axonal brain injuryJPRN-UMIN000013730europsychology group of department of neuropsychiatry, Kyoto University Hospital40
招募中
不适用
A Study on the symptomatology and diagnostic methodology of Virana SilaethumamCTRI/2017/06/008946P Sharmila30
已完成
不适用
Comparision of Maghavatham in Siddha Literature with Modern DiagnosisCTRI/2019/12/022327Ayothidoss pandithar hospital14
尚未招募
不适用
Study evaluating Symptom and Distress screening tools in initiating early supportive care in cancer patients treated with curative radiation therapyCTRI/2022/01/039478Debnarayan Dutta
招募中
不适用
a study on Siddha diagnostic term of VathakannagamCTRI/2017/07/009003ational Institute of Siddha20